Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Novel routes to myo-inositol 1,4,5-trisphosphate and a phosphorothioate analogue involving mixed P(V) and P(III) chemistry have been developed. Phosphorylation of 2,3,6-tri-O-benzyl-myo-inositol 1-[di-(2,2,2-trichloroethyl) phosphate] with bis(2,2,2-trichloroethyl) phosphorochloridate gave a mixture of the 1,4- and 1,5-bisphosphate derivatives from which the 1,4-bis[di-(2,2,2-trichloroethyl) phosphate] 9 crystallised. Phosphitylation of HO-5 in 9 followed by oxidation yielded the 1,4-bis[di-(2,2,2-trichloroethyl) phosphate] 5-[di-(2-cyanoethyl) phosphate] which was deblocked using sodium in liquid ammonia to give (±)-myo-inositol 1,4,5-trisphosphate. Phosphitylation of HO-5 in 9 followed by sulphoxidation generated the 1,4-bis[di-(2,2,2-trichloroethyl) phosphate] 5-[di-(2-cyanoethyl) thiophosphate] which was deblocked to give (±)-myo-inositol 1,4-bisphosphate 5-phosphorothioate. Removal of the 2,2,2-trichloroethyl group, using sodium in liquid ammonia, represents a new method for removing this protecting group. © 1992.

Original publication




Journal article


Carbohydrate Research

Publication Date





177 - 187